SMTI
Sanara MedTech Inc.
+0.02 (+0.06%)35.12USD26.3K成交股數323M市值–本益比(近四季)2.9股價營收比+9.0%營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 28.1M+9% | 27.8M+19% | 27.5M+27% | 26.3M+31% | 25.8M+39% | 23.4M+32% | 21.7M+35% | 20.2M+28% | 18.5M | 17.7M | 16.0M | 15.8M |
| 營業成本 | 2.0M | 1.9M | 1.9M | 1.9M | 1.9M | 1.8M | 2.0M | 2.0M | 1.9M | 1.8M | 1.8M | 2.2M |
| 毛利 | 26.2M+10% | 25.9M+20% | 25.7M+30% | 24.5M+35% | 23.9M+43% | 21.6M+36% | 19.7M+38% | 18.2M+34% | 16.6M | 15.9M | 14.3M | 13.6M |
| 毛利率 | 93.0% | 93.1% | 93.2% | 92.9% | 92.5% | 92.2% | 90.8% | 90.0% | 89.8% | 89.9% | 89.1% | 86.1% |
| 研發費用 | 1.2M | 760K | 2.0M | 1.0M | 1.1M | 950K | 784K | 986K | 946K | 652K | 986K | 1.2M |
| 銷售管理費用 | 22.6M | 21.9M | 20.1M | 19.9M | 19.6M | 19.1M | 17.4M | 19.0M | 16.2M | 16.3M | 13.9M | 13.8M |
| 營業利益 | 1.8M-28% | 2.6M+221% | 1.1M+35% | 2.9M-202% | 2.5M-262% | 826K-465% | 779K-186% | −2.9M+55% | −1.5M | −226K | −907K | −1.9M |
| 營業利益率 | 6.3% | 9.5% | 3.8% | 11.2% | 9.6% | 3.5% | 3.6% | -14.3% | -8.3% | -1.3% | -5.7% | -11.8% |
| 稅後淨利 | −453K-78% | 459K-113% | 73.5M-2672% | −30.4M+768% | −2.0M+14% | −3.5M-142% | −2.9M+170% | −3.5M+92% | −1.8M | 8.4M | −1.1M | −1.8M |
| 淨利率 | -1.6% | 1.7% | 266.9% | -115.5% | -7.8% | -15.1% | -13.2% | -17.4% | -9.5% | 47.3% | -6.6% | -11.6% |
| 稀釋 EPS | -0.05-78% | 0.05-112% | -0.32-6% | -3.40+729% | -0.23+10% | -0.41+1267% | -0.34+162% | -0.41+86% | -0.21 | -0.03 | -0.13 | -0.22 |
| 稀釋股數 | 8.7M | 9.0M | 8.6M | 8.9M | 8.9M | 8.6M | 8.5M | 8.5M | 8.4M | 8.3M | 8.3M | 8.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 15.4M | 13.6M | 16.6M | 14.9M | 17.0M | 20.7M | 16.3M | 6.2M | 2.8M | 5.1M | 6.2M | 6.1M |
| 應收帳款 | 12.6M | 13.6M | 12.0M | – | – | – | – | – | – | – | – | – |
| 存貨 | 3.5M | 3.1M | 3.9M | 3.4M | 3.5M | 3.2M | 3.0M | 3.6M | 4.2M | 4.7M | 5.0M | 4.4M |
| 總資產 | 69.1M | 69.3M | 72.9M | 71.1M | 98.8M | 96.4M | 88.5M | 73.4M | 70.9M | 73.9M | 73.9M | 73.9M |
| 有息負債 | 46.5M | 46.2M | 46.0M | 45.1M | 44.2M | 43.4M | 30.1M | 14.4M | 8.8M | 9.1M | 9.5M | – |
| 總負債 | 61.2M | 62.3M | 67.0M | 64.9M | 63.4M | 59.7M | 49.1M | 32.0M | 27.9M | 29.3M | 31.4M | 17.3M |
| 股東權益 | 7.9M | 7.0M | 5.9M | 6.1M | 35.4M | 36.7M | 39.8M | 41.7M | 43.3M | 44.8M | 44.3M | 41.1M |
| 負債比 | 88.5% | 89.9% | 91.9% | 91.4% | 64.2% | 62.0% | 55.4% | 43.6% | 39.3% | 39.6% | 42.5% | 23.4% |
| 淨現金(現金 − 有息負債) | −31.1M | −32.6M | −29.4M | −30.2M | −27.3M | −22.7M | −13.8M | −8.2M | −5.9M | −4.0M | −3.2M | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.5M+23% | – | – | – | −2.0M | – | – | −1.6M | – | – | – |
| 資本支出 | – | 44K | – | – | – | 1.7M | – | – | 66K | – | – | – |
| 自由現金流 | – | −2.5M-33% | – | – | – | −3.7M | – | – | −1.7M | – | – | – |
| 折舊攤銷 | 619K | 587K | 1.5M | 611K | 689K | 1.1M | 697K | 1.1M | 1.1M | 1.1M | 998K | 804K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -9.0% | – | – | – | -15.9% | – | – | -9.0% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 103M
| Soft Tissue Repair Products | 91.3M | 88.6% | +20.0% |
|---|---|---|---|
| Bone Fusion Products | 11.8M | 11.4% | +11.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 103M | +19.0% | 37.6M | 36.4% | -4.36 | 2.2M |
| FY2024 | 86.7M | +33.4% | 9.7M | 11.2% | -1.14 | −230K |
| FY2023 | 65.0M | +41.8% | 4.3M | 6.6% | -0.52 | −3.5M |
| FY2022 | 45.8M | +89.9% | −7.9M | -17.3% | -1.00 | −5.7M |
| FY2021 | 24.1M | +54.9% | −7.9M | -32.8% | -1.08 | −5.0M |
| FY2020 | 15.6M | +32.5% | −4.4M | -28.5% | -0.76 | −4.6M |
| FY2019 | 11.8M | +101.6% | −2.8M | -23.9% | -1.32 | −2.4M |
| FY2018 | 5.8M | – | −601K | -10.3% | 0.00 | 269K |